Hummingbird Bioscience's antibody therapy trial is part of anti-Covid-19 effort, says co-founder

The key to tackling the coronavirus pandemic is "building an arsenal of preventative options" such as vaccinations and treatments like antibody therapies, says Jerome Boyd-Kirkup, co-founder and chief scientific officer of the biotech firm.
Tue, Nov 17 202012:29 AM EST